Skip to main content

Table 1 Demographics and results

From: Dobutamine induced changes in aortic stiffness: influence of obesity in middle aged and elderly individuals with hypertension, diabetes or coronary artery disease

Measure BMI < 27.45 (N=98) BMI 27.45-32 (N=101) BMI > 32 (N=103) p-value with BMI
Age 70.3 (8.0) 68.9 (7.8) 66.6 (8.0) 0.0003
55-64 24 (24.5 %) 35 (34.6%) 48 (46.6%)  
65-74 40 (40.8%) 38 (37.6%) 34 (33.0%)  
75+ 34 (34.7%) 28 (27.7%) 21 (20.9%)  
Female 50 (51.0%) 47 (46.5%) 71 (68.9%) 0.018
Race     0.0017
Caucasian 88 (89.8%) 80 (79.2%) 71 (68.9%)  
African Am. 6 (11.1%) 17 (31.5%) 31 (30.1%)  
Prior HTN 88 (89.8%) 92 (91.0%) 98 (95.2%) 0.23
Prior DM     0.018
None 64 (65.3%) 60 (59.4%) 55 (53.4%)  
< 5 years 34 (34.7%) 33 (32.7%) 40 (38.8%)  
= 5 years 0 8 (7.9%) 8 (7.8%)  
Prior CAD 27 (27.6%) 22 (21.8%) 16 (15.5%) 0.34
SQ fat 143.1 (56.7) 202.9 (73.7) 325.5 (132.4) < 0.0001
Visceral fat 142.6 (72.6) 197.3 (94.7) 238.4 (97.8) < 0.0001
Taking drugs     
ACE 48 (49.0%) 50 (49.5%) 39 (37.9%) 0.27
ARB 4 (4.2%) 4 (4.2%) 3 (2.9%) 0.73
Statin 64 (65.4%) 64 (65.4%) 69 (67.0%) 0.82
Beta blocker 45 (45.9%) 45 (45.9%) 41 (39.8%) 0.43
Ca Ch. BL. 23 (23.5%) 23 (23.5%) 25 (24.5%) 0.67
Rest_55-64 1.618 ± 0.119 1.528 ± 0.096 1.45 ± 0.069  
Stress_55-64 1.528 ± 0.107 1.371 ± 0.103 1.513 ± 0.092  
Rest_65-74 1.719 ± 0.074 1.63 ± 0.075 1.739 ± 0.089  
Stress_65-74 1.537 ± 0.07 1.842 ± 0.102 1.701 ± 0.084  
Rest_75+ 1.898 ± 0.08 1.848 ± 0.103 1.79 ± 0.088  
Stress_75+ 1.694 ± 0.11 1.784 ± 0.123 1.962 ± 0.152